Log In / Sign Up

HB 5323

  • Rhode Island House Bill
  • 2017 Regular Session
  • Introduced in House Feb 01, 2017
  • House
  • Senate
  • Governor

AN ACT RELATING TO BUSINESSES AND PROFESSIONS - PHARMACEUTICAL COST TRANSPARENCY (Directs the state board of pharmacy, in collaboration with the Rhode Island department of health, to annually identify up to fifteen (15) prescription drugs on which the state spends significant health care dollars due to increases in costs.)

View Latest Bill Text
Sign In to Follow

Bill Subjects

Prescription Drugs Health & Safety

Abstract

Bill Sponsors (5)

Lombardi

     
Primary

Raymond Hull

  • Democratic
  • Representative
  • District 6
Primary

Daniel P. McKiernan

  • Democratic
Primary

Michael A. Morin

  • Democratic
Primary

Mary Messier

  • Democratic
  • Representative
  • District 62
Primary

Votes

No votes to display

Actions

Feb 14, 2017

Rhode Island General Assembly

02/14/2017 Committee recommended measure be held for further study

Feb 10, 2017

Rhode Island General Assembly

02/10/2017 Scheduled for hearing and/or consideration (02/14/2017)

Feb 01, 2017

Rhode Island General Assembly

02/01/2017 Introduced, referred to House Corporations

Bill Text

Bill Text Versions Format
5323 PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Rhode Island General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.